Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma
Preprint
Abstract
While chimeric antigen receptor (CAR) T-cell therapies are showing highly promising first results in neuroblastoma, immunosuppressive tumor microenvironments (TME) limit T cell persistence and durable clinical efficacy. To improve CAR T-cell efficacy further, we applied a multi-omics approach including single-cell RNA sequencing and proteomics, which identified 13 targetable immunosuppressive factors in neuroblastoma. Of these, macrophage migration inhibitory factor (MIF) and midkine (MDK) were validated across multiple published RNA datasets. Moreover, they were secreted in high abundance by neuroblastoma tumoroids. Functional validation experiments revealed MIF as a potent inhibitor of CAR T-cells, in vitro and in vivo. Degradation of MIF by PROTAC technology significantly enhanced CAR T-cell activation targeting GPC2 and B7-H3, providing a potential intervention against MIF. By defining the immunosuppressive effects of neuroblastoma’s TME on CAR T-cell efficacy, particularly the pivotal role of MIF, we provide a therapeutic strategy for improving adoptive cell therapies for this pediatric malignancy.Keywords
All Related Versions
- Published version: European Journal of Cancer, 218, 115263.
This publication has 83 references indexed in Scilit:
- Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer CellsAngewandte Chemie International Edition, 2021
- Assessment of programmed death‐ligand 1 expression and tumor‐associated immune cells in pediatric cancer tissuesCancer, 2017
- Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune EvasionStem Cells, 2016
- Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future OpportunitiesMedicinal Research Reviews, 2016
- Neuroblastoma triggers an immunoevasive program involving galectin‐1‐dependent modulation of T cell and dendritic cell compartmentsInternational Journal of Cancer, 2011
- Serum macrophage migration‐inhibitory factor as a diagnostic and prognostic biomarker for gastric cancerCancer, 2009
- Structural characterization andin vivo immunosuppressive activity of neuroblastoma GD2Glycoconjugate Journal, 1996
- Immunosuppressive activity of human neuroblastoma tumor gangliosidesInternational Journal of Cancer, 1989
- Shedding of GD2 ganglioside by human neuroblastomaInternational Journal of Cancer, 1987
- Factors influencing survival of children with nonmetastatic neuroblastomaCancer, 1976